Skip to content
CancerIndex

Publication

Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells.

Sepideh Salehipour-Bavarsad, Christian Iking, Jonas Kammertöns, Caroline Bouchard, Marion Meixner, Michael Daude, Wieland Steinchen, Felix Terwesten, Johanna Senst, David Vonhören, Sinja Rakow, Anne Kagerhuber, Sona Martirosian, Katrin Roth, Daniel Hilger, Stefanie Dörr, Gina Bach, Van Tuan Trinh, Anett Hauser, Frank Abendroth, Olalla Vázquez, Gert Bange, Jörg Walter Bartsch, Detlef Klaus Bartsch, Peter Kolb, Wibke E Diederich, Uta-Maria Bauer

Journal of medicinal chemistrySep 10, 2026PMID 42720487doi:10.1021/acs.jmedchem.5c03281 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 15, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260915-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

A substantial body of research implicates PRMTs in the pathogenesis of human diseases, primarily as oncoproteins or tumor suppressors in cancer. Starting from structure-based in silico screening of small-molecule databases, we predicted, synthesized, and assayed compounds aimed at specifically…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.